Redesigning conventional drug development to function efficiently during COVID-19 and other pandemics is essential. This week I had the opportunity to chat with two gentlemen who are invested in doing this critically important work. Professor Gareth Griffiths and Professor Saye Khoo explain how their platform, AGILE, is recreating conventional drug development. Take a listen below.
Learn more about W2O via our About or Healthcare pages
Leave a Reply